The tumor-specific immune landscape in HPV+ head and neck cancer

JP Conarty, A Wieland - Viruses, 2023 - mdpi.com
Human papillomaviruses (HPVs) are the causative agent of several anogenital cancers as
well as head and neck cancers, with HPV+ head and neck squamous cell carcinoma …

Is High-Risk Sexual Behavior a Risk Factor for Oropharyngeal Cancer?

G Wichmann, J Rudolph, S Henger, C Engel, K Wirkner… - Cancers, 2023 - mdpi.com
Simple Summary Several lines of evidence established a link between high-risk (HR) sexual
behavior (SB), the persistence of human papillomavirus (HPV) DNA in saliva, and the …

[HTML][HTML] Surveillance of human papillomavirus through salivary diagnostics-A roadmap to early detection of oropharyngeal cancer men

A Wijesekera, CE Weeramange, S Vasani… - Tumour Virus …, 2024 - Elsevier
Human papillomavirus (HPV) is the most common sexually transmitted disease. Certain
strains have the potential to cause malignancy in multiple anatomical sites if not cleared by …

Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study

G D'Souza, SR Tewari, T Troy, T Waterboer, L Struijk… - Cancer, 2023 - Wiley Online Library
Background Human papillomavirus (HPV)‐related oropharyngeal cancer screening is being
explored in research studies, but strategies to identify an appropriate population are not …

Antibodies against high‐risk human papillomavirus proteins as markers for noncervical HPV‐related cancers in a Black South African population, according to HIV …

MG Singini, M Muchengeti, F Sitas… - … Journal of Cancer, 2024 - Wiley Online Library
Human papillomavirus (HPV) proteins may elicit antibody responses in the process toward
HPV‐related malignancy. However, HPV seroepidemiology in noncervical HPV‐related …

Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis

EM Rettig, T Waterboer, E Sim, DL Faden… - Oral …, 2023 - pubmed.ncbi.nlm.nih.gov
Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA
before head and neck cancer diagnosis Relationship of HPV16 E6 seropositivity with …

Development and external validation of a head and neck cancer risk prediction model

CDL Smith, AD McMahon, DM Lyall, M Goulart… - Head & …, 2024 - Wiley Online Library
Background Head and neck cancer (HNC) incidence is on the rise, often diagnosed at late
stage and associated with poor prognoses. Risk prediction tools have a potential role in …

Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR

F Rosing, M Meier, L Schroeder, S Laban… - Microbiology …, 2024 - Am Soc Microbiol
The incidence rate of human papillomavirus-driven oropharyngeal cancer (HPV-OPC) is
increasing in countries with high human development index. HPV cell-free DNA (cfDNA) …

[HTML][HTML] Blood-based screening for HPV-associated cancers

D Das, S Hirayama, L Aye, ME Bryan, S Naegele… - medRxiv, 2024 - ncbi.nlm.nih.gov
Background: HPV-associated oropharyngeal cancer (HPV+ OPSCC) is the most common
HPV-associated cancer in the United States yet unlike cervical cancer lacks a screening test …

ctHPV-DNA-basierte Präzisionsonkologie für Patienten mit Oropharynxkarzinom–wo stehen wir?

N Wuerdemann, S Joosse, C Klasen… - Laryngo-Rhino …, 2023 - thieme-connect.com
Das humane Papillomavirus (HPV) ist im Kopf-Hals-Bereich ein gesicherter ätiologischer
Faktor für die Entstehung von oropharyngealen Plattenepithelkarzinomen (engl. OPSCC) …